2691. Does Janus Kinase Inhibitor Increase the Risk of Herpes Zoster in Rheumatoid Arthritis Patients in Saudi Arabia? A Multicenter Retrospective Cohort Study

BACKGROUND: JAK inhibitors (JAKi) are targeted synthetic disease-modifying antirheumatic drugs. Current evidence showed they are effective in either post Conventional or Biologic disease-modifying anti-rheumatic drugs ( cDMARDs) (bDMARDs) in patients with moderate to severe rheumatoid arthritis (RA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Fida, Kaki, Reham, Abudaowd, Ola, Attar, Suzan, Almoallim, Hani, Salama, Gamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678830/
http://dx.doi.org/10.1093/ofid/ofad500.2302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678830/
http://dx.doi.org/10.1093/ofid/ofad500.2302

Ejemplares similares